Merck & Company, Inc. company logo

# 1st Gen Model Merck & Company, Inc. Pharmaceutical preparations

Subscribe >> Deal exit on
Dec. 18, 2017
Deal entry on
Dec. 18, 2017
0.05%Expected margin
65.00% successful of 60 deals
$56.24 Last close price
at 15-dec-2017

MRK

Model's trade recommendations 1.46% Return for period

2.07% Annual return

$155.05B Market Cap

β 0.76  

MRK

Model (following trade recommendations)

MRK

Underlying stock

S&P 500

Index
Return for period 1.46%
1.88%
1.78%
52wk return -6.63%
-9.93%
16.82%
52wk Range
54.10—66.55
2000.54—2399.63
Sortino ratio 0.32
Sharpe ratio 0.27
Norm. RMSE 0.34%
Downside risk 6.39%
Volatility 7.60%
  • 1.88 (3.30%) Div (Yield)
  • BUY Analysts consensus recommendation

Merck & Co., Inc., a leading global biopharmaceutical company known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases. Through their prescription medicines, vaccines, biologic therapies and animal health products, they work with customers and operate in more than 140 countries to deliver innovative health solutions. Merck also demonstrate their commitment to increasing access to health care through far-reaching policies, programs and partnerships. Today, Merck continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world - including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer's disease and infectious diseases including HIV and Ebola.

Industry sector: Medical

Sector classification: Pharmaceutical preparations

Deep Learning based analysis and prediction model for Merck & Company, Inc. (MRK) stock is a 1st Generation Non-linear Autoregresive with exogenous variable(s) (NARX) model based on the Recurrent Neural Network architecture.

Model is in the production pipeline since Sept. 10, 2014.

Market data for MRK model training are being downloaded from the Quandl premium datasets on a daily basis.

Model is being retrained on a daily basis.

Float 2718M
P/E 14.63
Shares Outstanding 2724M
% Held by Insiders 0.25%
% Held by Institutions 73.84%
EPS (last reported FY) $3.78
EPS (last reported Q) $1.11
EPS, estimated (last reported Q) $1.03
Total revenues $40 B
Net income $4 B